Snow blankets northern Saudi region of Al-Jouf    Syrian Air to resume operation between Damascus and Jeddah on Nov. 7 after a hiatus of 8 years    21,370 illegal residents arrested in a week    Bronze Age town discovered in Khaybar Oasis    New mechanism for reviewing taxi fares via applications    Harris and Trump in dead heat as Election Day nears    Spain flooding one of many global extreme weather disasters: UN weather agency    EU braces for potential shifts in transatlantic relations ahead of US presidential election    Israeli army nearing end of ground offensive in southern Lebanon, reports indicate    Al Hilal sets record for longest unbeaten streak across all domestic competitions    Al Nassr and Al Hilal share points in intense Riyadh Derby draw    Riyadh's Sports Boulevard receives Platinum ActiveScore certifications    ImpaQ: Riyadh to host first Impact Makers Forum in December    Saudi Arabia ranks 12th globally in international visitor spending in 2023    Hidden sugars in Asia's baby food spark concerns    Saleh Al Shehri strike seals Al Ittihad's Sea Derby win over Al Ahli    HONOR unveils pre-order of the stunning HONOR MagicBook Art 14 Featuring an ultra-slim design, HONOR Eye Comfort Display and AI Cross-OS WorkStation    Derby Week makes its debut in the Roshn Saudi League    Teri Garr, Young Frankenstein and Tootsie star, dies at 79    Indonesia Days event celebrates cultural diversity at Al Suwaidi Park    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Muted Eid celebrations for millions of Nigerian Muslims    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



UK approves AstraZeneca/Oxford COVID-19 vaccine
Published in The Saudi Gazette on 30 - 12 - 2020

Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by AstraZeneca and Oxford University, as it battles a major winter surge driven by a new, highly contagious variant of the virus, Reuters reported.
Matt Hancock, UK Secretary of State for Health and Social Care said that the vaccine would be made available to some of the poorest regions of the world at a low cost, helping protect countless people from this awful disease.
"It is a tribute to the incredible UK scientists at Oxford University and AstraZeneca whose breakthrough will help to save lives around the world. I want to thank every single person who has been part of this British success story. While it is a time to be hopeful, it is so vital everyone continues to play their part to drive down infections," he added.
The approval paves the way for millions more people to be immunized against the virus, with the UK ordering 100 million doses from AstraZeneca, which can vaccinate 50 million people.
The NHS has already vaccinated hundreds of thousands of patients with the Pfizer/BioNTech vaccine and the government said its rollout would continue.
The health service will now start preparing to roll out the Oxford University/AstraZeneca vaccine, with hopes to begin administering the jabs in the New Year.
Unlike the Pfizer/BioNTech jab, the newly approved vaccine can be stored at room temperature rather than -70C, which means it will be easier to transport to care homes and doctor's surgeries.
It is also cheap and easy to mass-produce, which will help the UK quickly expand its immunization campaign.
"The government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorize Oxford University/AstraZeneca's COVID-19 vaccine for use," Westminster said in a statement.
"This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness."
AstraZeneca chief executive Pascal Soriot hailed the "important day" for the millions who would get the jab.
He said: "It has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit. We would like to thank our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants.
The Joint Committee on Vaccination and Immunization (JCVI) will also publish its latest advice for the priority groups to receive this vaccine. It has advised a shift in strategy, with priority to be given to getting as many people as possible in at-risk groups their first dose, rather than providing the required two doses in as short a time as possible.
"Everyone will still receive their second dose and this will be within 12 weeks of their first. The second dose completes the course and is important for longer-term protection," the UK government said.
It added that administering the vaccines in this way will maximize the benefits of both vaccines, according to the JCVI's advice.
"It will ensure that more at-risk people are able to get meaningful protection from a vaccine in the coming weeks and months, reducing deaths and starting to ease pressure on our NHS." — Agencies


Clic here to read the story from its source.